Compare Ferrari NV (RACE) vs 10X Genomics Inc (TXG) Price & Performance

Ferrari (RACE) trades at $405.94, down 0.98% on the day, with technical indicators showing a bearish trend while fundamentals remain strong. The company reported solid Q2 2026 earnings of $2.99 EPS, beating estimates, and maintains robust profitability with 22.25% net margins. Recent news highlights Ferrari's first electric vehicle selling for $40 million at auction, demonstrating brand strength. Analyst consensus remains bullish with a $462.67 price target representing 14% upside potential from current levels.

Ferrari presents a compelling growth story with premium valuation justified by strong fundamentals, though elevated multiples leave little room for execution missteps. Key risks include luxury market cyclicality and electric vehicle transition challenges, while institutional buying activity supports long-term confidence. The stock's current technical weakness may present entry opportunities for investors believing in the company's brand power and margin stability.

TXG trades at $65.60, up 4.71% today, with strong technical momentum showing bullish moving averages and key support at $63. Fundamentally, the company demonstrates improving trends with Q2 2026 earnings beating estimates and revenue growth guidance raised, though profitability remains negative with a -12.18% net margin. Recent patent victory against Parse Biosciences strengthens competitive positioning.

The outlook remains cautiously optimistic with analyst consensus at 45% buy ratings and $50.78 price target. Key opportunities include Atera platform adoption and consumables growth, while risks center on valuation premiums and ongoing profitability challenges. The stock trades near resistance at $67 with institutional interest showing mixed signals.